We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges

By HospiMedica International staff writers
Posted on 30 Jun 2025

A new study presented at ASM Microbe 2025 has provided strong evidence that higher levels of fungal spores in the air are closely associated with spikes in influenza and COVID-19 cases. More...

The findings suggest that tracking airborne fungal spores could serve as an effective early warning tool for anticipating respiratory virus outbreaks, aiding public health preparedness.

The research, conducted by scientists at Lynn University (Boca Raton, FL, USA), found that measuring fungal spore levels outdoors could be a reliable method for forecasting rises in flu and COVID-19 cases, particularly in the autumn months. The team aimed to explore the short-term effects of environmental factors—specifically fungal spores and pollen—on the occurrence or intensification of viral respiratory infections like influenza and COVID-19. For this investigation, they analyzed daily data from 2022 to 2024 in two major healthcare regions in Puerto Rico: San Juan and Caguas. Puerto Rico provides a distinct setting for this research, given its continuous, endemic presence of airborne fungi and pollen throughout the year. Although these environmental elements are already known to influence conditions such as asthma and allergies, their relationship to viral infection patterns has not been extensively studied. The dataset included daily case counts for flu and COVID-19, along with the corresponding measurements of airborne fungal spores and pollen for those dates.

To determine whether elevated environmental exposure levels could predict upcoming viral infection spikes, the researchers applied both statistical analyses and machine learning techniques. These models evaluated whether high levels of fungal spores or pollen were linked to increased flu and COVID-19 case counts either within the same week or the following week—a concept referred to as a "lag-effect." The results revealed a strong correlation between high airborne fungal spore concentrations and increases in respiratory virus infections. This association did not hold for pollen levels. In many cases, a rise in fungal spore concentrations was followed by a noticeable increase in infection numbers just days later. The predictive models were particularly effective in forecasting infection surges during the fall season across both study regions—San Juan and Caguas. Pollen levels, on the other hand, did not demonstrate any predictive capability. As a next step, the researchers intend to examine whether these environmental factors are also linked to more severe health outcomes, such as hospital admissions or deaths. They also plan to investigate whether similar environmental-infection patterns occur in geographic regions outside of Puerto Rico.

“The findings from our study suggest that monitoring airborne fungal spore levels could help predict short-term outbreaks (spikes) of flu and COVID-19, giving public health systems an early warning signal,” said presenting study author Félix E. Rivera-Mariani, Ph.D. “Our findings also highlight the potential role of environmental factors—not just person-to-person spread—in contributing to the incidence of respiratory viral infections. That could open new doors for targeted public health alerts, especially in areas with high outdoor airborne fungi.”

Related Links:
Lynn University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Endoscopy Display
E190
New
Instrument Cabinet
TRZY-068
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.